Nita G Valikodath, Jianwei D Li, William Raynor, Joseph A Izatt, Cynthia A Toth, Lejla Vajzovic
{"title":"术中 OCT 引导下的人体视网膜下治疗容积测量。","authors":"Nita G Valikodath, Jianwei D Li, William Raynor, Joseph A Izatt, Cynthia A Toth, Lejla Vajzovic","doi":"10.1177/24741264241253920","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To evaluate a recently developed technique using intraoperative optical coherence tomography (OCT) to measure subretinal tissue plasminogen activator (tPA) volumes in patients with submacular hemorrhage secondary to exudative age-related macular degeneration (AMD). <b>Methods:</b> Three patients (72 to 83 years old) had 25-gauge pars plana vitrectomy, subretinal tPA, and a partial gas fill. An investigational intraoperative OCT system with a modified widefield noncontact indirect viewing apparatus was used to image subretinal tPA blebs. Using the recently developed technique, the volume and surface area in the segmented region of interest were determined. <b>Results:</b> In each case, the delivered tPA volume measured from the syringe differed from the intraoperative OCT-measured subretinal tPA volume: Patient 1, 130 µL from syringe, 118 µL based on intraoperative OCT, 9% difference; Patient 2, 140 µL, 50 µL, 64%; Patient 3, 110 µL, 122 µL, 11%. The total bleb surface area was 129 mm<sup>2</sup> in Patient 1, 55 mm<sup>2</sup> in Patient 2, and 106 mm<sup>2</sup> in Patient 3. <b>Conclusions:</b> This was the first human study to implement and evaluate intraoperative OCT image-based methods to obtain volumetric bleb measurements in patients receiving subretinal tPA for exudative AMD. This proof-of-concept study showed that intraoperative OCT-obtained bleb volume differed from intraoperative recordings, which could be explained by tPA delivery into the vitreous, efflux through the retinotomy, or human error. Intraoperative OCT can provide visualization and quantification of subretinal tPA bleb volume and surface area, which has implications for improved safety, efficacy, and analysis of the effects of subretinal drug delivery.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":"8 5","pages":"587-592"},"PeriodicalIF":0.5000,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418694/pdf/","citationCount":"0","resultStr":"{\"title\":\"Intraoperative OCT-Guided Volumetric Measurements of Subretinal Therapy Delivery in Humans.\",\"authors\":\"Nita G Valikodath, Jianwei D Li, William Raynor, Joseph A Izatt, Cynthia A Toth, Lejla Vajzovic\",\"doi\":\"10.1177/24741264241253920\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Purpose:</b> To evaluate a recently developed technique using intraoperative optical coherence tomography (OCT) to measure subretinal tissue plasminogen activator (tPA) volumes in patients with submacular hemorrhage secondary to exudative age-related macular degeneration (AMD). <b>Methods:</b> Three patients (72 to 83 years old) had 25-gauge pars plana vitrectomy, subretinal tPA, and a partial gas fill. An investigational intraoperative OCT system with a modified widefield noncontact indirect viewing apparatus was used to image subretinal tPA blebs. Using the recently developed technique, the volume and surface area in the segmented region of interest were determined. <b>Results:</b> In each case, the delivered tPA volume measured from the syringe differed from the intraoperative OCT-measured subretinal tPA volume: Patient 1, 130 µL from syringe, 118 µL based on intraoperative OCT, 9% difference; Patient 2, 140 µL, 50 µL, 64%; Patient 3, 110 µL, 122 µL, 11%. The total bleb surface area was 129 mm<sup>2</sup> in Patient 1, 55 mm<sup>2</sup> in Patient 2, and 106 mm<sup>2</sup> in Patient 3. <b>Conclusions:</b> This was the first human study to implement and evaluate intraoperative OCT image-based methods to obtain volumetric bleb measurements in patients receiving subretinal tPA for exudative AMD. This proof-of-concept study showed that intraoperative OCT-obtained bleb volume differed from intraoperative recordings, which could be explained by tPA delivery into the vitreous, efflux through the retinotomy, or human error. Intraoperative OCT can provide visualization and quantification of subretinal tPA bleb volume and surface area, which has implications for improved safety, efficacy, and analysis of the effects of subretinal drug delivery.</p>\",\"PeriodicalId\":17919,\"journal\":{\"name\":\"Journal of VitreoRetinal Diseases\",\"volume\":\"8 5\",\"pages\":\"587-592\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2024-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418694/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of VitreoRetinal Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/24741264241253920\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of VitreoRetinal Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/24741264241253920","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:评估一种最新开发的技术,该技术利用术中光学相干断层扫描(OCT)测量渗出性年龄相关性黄斑变性(AMD)继发性黄斑下出血患者的视网膜下组织纤溶酶原激活剂(tPA)容量。测量方法三名患者(72 至 83 岁)接受了 25 号玻璃体旁切除术、视网膜下 tPA 和部分气体填充。研究人员使用带改良宽视场非接触式间接观察装置的术中 OCT 系统对视网膜下 tPA 泡进行成像。利用最近开发的技术,确定了感兴趣区段的体积和表面积。结果显示在每个病例中,从注射器中测得的 tPA 容量与术中 OCT 测得的视网膜下 tPA 容量不同:患者 1 的注射器注射量为 130 µL,术中 OCT 测量值为 118 µL,两者相差 9%;患者 2 的注射器注射量为 140 µL,术中 OCT 测量值为 50 µL,两者相差 64%;患者 3 的注射器注射量为 110 µL,术中 OCT 测量值为 122 µL,两者相差 11%。患者 1 的眼泡总表面积为 129 平方毫米,患者 2 为 55 平方毫米,患者 3 为 106 平方毫米。结论:这是第一项对接受视网膜下 tPA 治疗渗出性 AMD 的患者进行术中 OCT 图像测量眼泡体积的方法进行实施和评估的人体研究。这项概念验证研究表明,术中 OCT 获得的眼泡体积与术中记录不同,这可能是由于 tPA 被输送到玻璃体内、通过视网膜切口外流或人为失误造成的。术中 OCT 可提供视网膜下 tPA 眼泡体积和表面积的可视化和量化,这对提高安全性、有效性和分析视网膜下给药的效果具有重要意义。
Intraoperative OCT-Guided Volumetric Measurements of Subretinal Therapy Delivery in Humans.
Purpose: To evaluate a recently developed technique using intraoperative optical coherence tomography (OCT) to measure subretinal tissue plasminogen activator (tPA) volumes in patients with submacular hemorrhage secondary to exudative age-related macular degeneration (AMD). Methods: Three patients (72 to 83 years old) had 25-gauge pars plana vitrectomy, subretinal tPA, and a partial gas fill. An investigational intraoperative OCT system with a modified widefield noncontact indirect viewing apparatus was used to image subretinal tPA blebs. Using the recently developed technique, the volume and surface area in the segmented region of interest were determined. Results: In each case, the delivered tPA volume measured from the syringe differed from the intraoperative OCT-measured subretinal tPA volume: Patient 1, 130 µL from syringe, 118 µL based on intraoperative OCT, 9% difference; Patient 2, 140 µL, 50 µL, 64%; Patient 3, 110 µL, 122 µL, 11%. The total bleb surface area was 129 mm2 in Patient 1, 55 mm2 in Patient 2, and 106 mm2 in Patient 3. Conclusions: This was the first human study to implement and evaluate intraoperative OCT image-based methods to obtain volumetric bleb measurements in patients receiving subretinal tPA for exudative AMD. This proof-of-concept study showed that intraoperative OCT-obtained bleb volume differed from intraoperative recordings, which could be explained by tPA delivery into the vitreous, efflux through the retinotomy, or human error. Intraoperative OCT can provide visualization and quantification of subretinal tPA bleb volume and surface area, which has implications for improved safety, efficacy, and analysis of the effects of subretinal drug delivery.